DETAILED ACTION
Final
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Response to Amendment
The amendment filed on 12/04/2025 is entered and acknowledged by the Examiner. Claims 1-12 have been amended and are currently pending in the instant application.
The rejection of claims 1-12 under 35 U.S.C. 103 as being unpatentable over Yamaguchi (US 2003/0051807 Al) is maintained for the reasons of record.
Response to Arguments
Applicant's arguments filed on 12/04/2025 have been fully considered but they are not persuasive.
At pages 1-4 of the remark, Applicant’s main argument is Yamaguchi does not disclose a second epoxy resin having a viscosity of 100 cps or more and 500 cps or less at 20°C or more and 30°C or less as recited in amended claim 1. The Examiner respectfully disagrees with the Applicant’s remark.
As noted by the Applicant, Yamaguchi discloses a glycidyl-containing epoxy resin including a low viscosity epoxy resin (See [0027] of Yamaguchi). In one embodiment, Yamaguchi discloses the glycidyl-containing epoxy resin with a product name Epikote 154 (See [0057]; Table 1). Epikote 154 is commercially known to have a viscosity at 25°C, measured by ASTM D445, of 235-305 mPas (cps) (See Technical Data Sheet of Epikote Resin 154 by Westlake Epoxy, which was originally Yuka Shell Epoxy). Therefore, Yamaguchi discloses a glycidyl-containing epoxy resin includes a viscosity of 235-305 cps at 25°C. The glycidyl-containing epoxy resin (claimed second epoxy resin) of Yamaguchi has a viscosity within the claimed range of 100 cps or more and 500 cps or less and within the claimed temperature of 20°C or more and 30°C or less as recited in amended claim 1.
Based on the above rationale, the rejection of claims 1-12 over Yamaguchi is maintained.
Conclusion
THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to KHANH TUAN NGUYEN whose telephone number is (571)272-8082. The examiner can normally be reached M-F 9:00 AM to 5:00 PM EST.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Angela Brown-Pettigrew can be reached at (571) 272-2817. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/KHANH T NGUYEN/Primary Examiner, Art Unit 1761
Prosecution Insights